Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,038 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Study of TPI 287 in Patients With Advanced Malignancies

NCT00113724

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +8 more
Locations
  • Arizona Clinical Research Center Tucson, Arizona, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Georgetown University Medical Center/Lombardi Cancer Center Washington D.C., District of Columbia, United States
  • New York Medical College Valhalla, New York, United States
View Trial Details
Completed

Safety and Tolerability Study of INNO-406 to Treat Chronic Myeloid Leukemia or Acute Lymphocytic Leukemia

NCT00352677

Conditions
Acute Lymphocytic Leukemia, Bone Marrow Diseases, Chronic Disease, +18 more
Locations
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Charite University of Medicine Berlin, Germany
  • Johann Wolfgang Goethe Universität Frankfurt am Main, Germany
View Trial Details
Completed

PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia

NCT00494897

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Hospital General de Alicante Alicante, Spain
  • Hospital Ntra. Sra. Sonsoles Ávila, Avila, Spain
  • Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
  • Hospital Clínic Barcelona, Spain
View all 87 locations
View Trial Details
Completed

Study of ONTAK in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL)

NCT00055146

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • Pacific Coast Hematology/Oncology Medical Group, Inc. Fountain Valley, California, United States
  • UCSD School of Medicine La Jolla, California, United States
  • Rush-Presbyterian St. Luke's Cancer Center Chicago, Illinois, United States
  • Weill Medical College of Cornell University/New York Presbyterian Hospital New York, United States
View all 14 locations
View Trial Details
Completed

Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma

NCT00070083

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States
  • British Columbia Cancer Agency - Centre for the Southern Interior Kelowna, British Columbia, Canada
  • Fraser Valley Cancer Centre at British Columbia Cancer Agency Surrey, British Columbia, Canada
  • British Columbia Cancer Agency - Vancouver Cancer Centre Vancouver, British Columbia, Canada
View Trial Details
Completed

Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

NCT00045136

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • University of California Davis Cancer Center Sacramento, California, United States
  • Veterans Affairs Medical Center - Tennessee Valley Healthcare System - Nashville Campus Nashville, Tennessee, United States
  • University of Texas - MD Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions